Hopes on immunotherapy targeting B7-H3 in neuroblastoma
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference23 articles.
1. Therapeutic targeting of the anaplastic lymphoma kinase (ALK) in neuroblastoma-a comprehensive update;Brenner;Pharmaceutics,2021
2. Monoclonal antibody therapies for high risk neuroblastoma;Furman;Biologics,2021
3. Molecular targeting therapies for neuroblastoma: progress and challenges;Zafar;Med. Res. Rev.,2021
4. Anti-GD2 directed immunotherapy for high-risk and metastatic neuroblastoma;Chan;Biomolecules,2022
5. Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1;Mabe;Nat. Cancer,2022
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Editorial: Co-inhibitory immune checkpoint proteins as biomarkers and therapeutic targets in cancer;Translational Oncology;2024-09
2. Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature;Frontiers in Oncology;2024-06-17
3. CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives;EJC Paediatric Oncology;2024-06
4. NR1D1‐transactivated lncRNA NUTM2A‐AS1 promotes chemoresistance and immune evasion in neuroblastoma via inhibiting B7‐H3 degradation;Journal of Cellular and Molecular Medicine;2024-05
5. Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation;EJNMMI Radiopharmacy and Chemistry;2024-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3